GSB Wealth Management, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSB Wealth Management, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$261,023
-40.8%
2,563
-41.4%
0.09%
-39.2%
Q2 2023$441,235
+9.7%
4,3730.0%0.14%
+8.3%
Q1 2023$402,276
+1.5%
4,373
+0.1%
0.13%
-6.4%
Q4 2022$396,288
+19.4%
4,3680.0%0.14%
+17.5%
Q3 2022$332,000
-10.0%
4,3680.0%0.12%
-4.8%
Q2 2022$369,000
-3.7%
4,3680.0%0.13%
+12.5%
Q1 2022$383,000
+0.3%
4,368
+0.1%
0.11%
+1.8%
Q4 2021$382,000
+11.0%
4,364
+3.7%
0.11%
-37.9%
Q3 2021$344,000
-17.3%
4,210
-7.8%
0.18%
+36.2%
Q2 2021$416,000
+6.7%
4,5640.0%0.13%0.0%
Q1 2021$390,000
-2.0%
4,564
+8.4%
0.13%
-92.7%
Q4 2020$398,000
+8.7%
4,2100.0%1.78%
+6.8%
Q3 2020$366,000
-0.5%
4,2100.0%1.67%
-18.6%
Q2 2020$368,000
+6.1%
4,2100.0%2.05%
-18.9%
Q1 2020$347,000
-13.0%
4,2100.0%2.53%
+54.4%
Q4 2019$399,000
+9.0%
4,2100.0%1.64%
-7.8%
Q3 2019$366,000
-4.7%
4,2100.0%1.78%
-11.3%
Q2 2019$384,000
-5.2%
4,2100.0%2.00%
+15.5%
Q1 2019$405,000
+12.2%
4,2100.0%1.74%
-8.9%
Q4 2018$361,000
-0.6%
4,2100.0%1.90%
+27.3%
Q3 2018$363,000
+14.2%
4,2100.0%1.50%
-0.7%
Q2 2018$318,000
-6.5%
4,2100.0%1.51%
-8.1%
Q1 2018$340,000
-3.7%
4,2100.0%1.64%
+3.2%
Q4 2017$353,000
-2.2%
4,2100.0%1.59%
-6.9%
Q3 2017$361,000
+2.8%
4,2100.0%1.71%
+7.5%
Q2 2017$351,000
+12.1%
4,2100.0%1.59%
+19.7%
Q1 2017$313,000
+2.0%
4,2100.0%1.33%
+10.5%
Q4 2016$307,0004,2101.20%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders